Showing results (1201-1210 of 1,427) with videos related to

Sort By:
Pageof 143
The Lancet. Oncology|December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trialAmit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid TumorsSuzanne Leijen, Robin M J M van Geel, Anna C Pavlick, et al.
Investigational New Drugs|July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsIvan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Gynecologic Oncology|November 7, 2017
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)Felicia T Roncolato, Dominique Berton-Rigaud, Rachel O'Connell, et al.
Biomolecules|March 25, 2020
Why Does Knocking Out NACHO, But Not RIC3, Completely Block Expression of α7 Nicotinic Receptors in Mouse Brain?Anish Deshpande, Remitha M Vinayakamoorthy, Brijesh K Garg, et al.
MMWR. Morbidity and Mortality Weekly Report|August 31, 2023
Vital Signs: Maternity Care Experiences - United States, April 2023Yousra A Mohamoud, Elizabeth Cassidy, Erika Fuchs, et al.
Scientific Reports|August 30, 2025
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysisToshikazu Kohira, Satoshi Oeda, Erina Eto, et al.
Emerging Infectious Diseases|September 21, 2016
Ebola Virus Disease in Children, Sierra Leone, 2014-2015Felicity Fitzgerald, Asad Naveed, Kevin Wing, et al.
BMC Medical Genomics|August 11, 2018
Additional germline findings from a tumor profiling programNeda Stjepanovic, Tracy L Stockley, Philippe L Bedard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous CarcinomaJoyce F Liu, Nicoletta Colombo, Amit M Oza, et al.
Pageof 143